Skip to content
The Kids Research Institute Australia logo
Donate

Search

Showing results for "1"

Nutrition

Our researchers are trying to learn more about the effect different types of food have on blood glucose levels and how to give the best insulin dose to manage a variety of foods.

Research results

Many of the Centre's researchers have been responsible for discovering and contributing to real game-changers, making a difference to children with diabetes.

News & Events

CHRISTMAS TECHNOLOGY TIPS

Summer holidays here we come! The holidays are finally here and while a lack of routine is welcomed by most, being out of routine can be challenging

News & Events

Student scholarship opportunities now open

We are excited to announce that applications are now open for our PhD scholarships and our Honours/Masters scholarships to support students pursuing

News & Events

Get involved in ENDIA

ENDIA (Environmental Determinants of Islet Autoimmunity) is a national observational study into the causes of Type 1 Diabetes in childhood.

News & Events

Teens with diabetes cope with the additional burden of CV protection

ACE inhibitors and statins are well tolerated in teenagers with Type 1 Diabetes but more evidence is required to demonstrate whether they are effective

News & Events

Diabetes link to deadly diseases

New research led by The Kids' PhD student Matthew Cooper has found that some children with T1D have an increased risk of developing vascular diseases.

Research

Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumors

Citation: Sek K, Chen AXY, Cole T, Armitage JD, Tong J, ……… Waithman J, Parish IA, et al. Tumor site-directed A1R expression enhances CAR T cell

Research

Realising the potential impact of artificial intelligence for rare diseases – A framework

Rare diseases (RD) are conditions affecting fewer than 1 in 2000 persons, with over 7000 largely genetic RDs affecting 3.5 %-5.9 % of the global population, or approximately 262.9–446.2 million people. The substantial healthcare burden and costs, such as the $1 trillion annual expense in the USA, highlight the urgent need for improved RD management. The International Rare Diseases Research Consortium (IRDiRC) addresses this need through global collaboration, aiming for timely and accurate diagnosis, development of 1000 new therapies, and methodologies to measure impact by 2027.

Research

ISPAD Clinical Practice Consensus Guidelines 2022: Definition, epidemiology, and classification of diabetes in children and adolescents

Citation: Libman I, Haynes A, Lyons S, Pradeep P, Rwagasor E, et al. ISPAD Clinical Practice Consensus Guidelines 2022: Definition, epidemiology, and